Immix Biopharma Retained Earnings (Accumulated Deficit) 2020-2024 | IMMX

Immix Biopharma retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Immix Biopharma Retained Earnings (Accumulated Deficit) 2020-2024 | IMMX

Immix Biopharma retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.